Premature Ovarian Insufficiency (POI) presents a significant challenge to women’s health, with far-reaching implications, both physically and emotionally. The potential implications include negative impacts on quality of life, fertility, bone health, cardiovascular function and cognitive health. Although hormone replacement therapy (HRT) can mitigate some of these effects, significant questions remain about the optimal management of POI
To improve the care of women with POI, an international expert group, including representation from ESHRE, ASRM, CRE-WHiRL and IMS collaborated to address 40 key questions through 145 recommendations. For healthcare professionals supporting women with POI, this is a must-read document.
You can access the guideline on the ESHRE website: https://www.eshre.eu/Guideline/POI
This guideline is an updated version and replaces the ESHRE Guideline on the management of women with POI (2016).